Until as recently as 2010, most of the treatment options for treating symptoms of late stage MS involved injecting one or many drugs.  New Multiple Sclerosis pill options are now available and three late stage studies are showing that Fingolimod and Cladribine are effective.  If the FDA gives its approval, it could mark a turning point in the treatment of Multiple Sclerosis.  Pill popping is much more convenient and tolerable for patients, and could mean they are more likely to stay on their treatment plans.  These two drugs are targeting the relapsing-remitting MS that is defined as relapsing episodes, usually progressively worse, followed by a period where the symptoms either completely or partially disappear.

A Multiple Sclerosis pill would be a real profit maker for the manufacturer.

Since no cure has yet been found for Multiple Sclerosis, pill treatment to manage the symptoms and prevent relapses would be …